We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.81B
AUM Growth
+$442M
Cap. Flow
+$410M
Cap. Flow %
22.65%
Top 10 Hldgs %
60.78%
Holding
481
New
48
Increased
103
Reduced
190
Closed
49

Sector Composition

Rank Sector Weight
1 Industrials 2.96%
2 Consumer Discretionary 2.09%
3 Financials 1.92%
4 Technology 1.77%
5 Energy 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
351
iShares Select Dividend ETF
DVY
$23.8B
$206K 0.01%
2,200
-2,650
-55% -$245K
KEY icon
352
KeyCorp
KEY
$23.8B
$205K 0.01%
10,919
-1,194
-10% -$21.6K
MCK icon
353
McKesson
MCK
$104B
$204K 0.01%
1,331
-63
-5% -$9.83K
GLD icon
354
SPDR Gold Trust
GLD
$131B
$203K 0.01%
1,670
-490
-23% -$59.6K
EZU icon
355
iShare MSCI Eurozone ETF
EZU
$9.38B
$200K 0.01%
4,612
-236
-5% -$9.88K
STPZ icon
356
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$507M
$200K 0.01%
3,833
WTS icon
357
Watts Water Technologies
WTS
$11.2B
$200K 0.01%
+2,894
New +$186K
NMR icon
358
Nomura Holdings
NMR
$28.3B
$193K 0.01%
34,561
-454
-1% -$2.6K
IVW icon
359
iShares S&P 500 Growth ETF
IVW
$70.5B
$191K 0.01%
5,328
IWP icon
360
iShares Russell Mid-Cap Growth ETF
IWP
$19.4B
$189K 0.01%
3,342
BRK.B icon
361
CALL
Berkshire Hathaway Class B
BRK.B
$1.1T
$183K 0.01%
+1,000
New +$177K
ARLZ
362
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$183K 0.01%
80,000
+50,000
+167% +$66.9K
F icon
363
Ford
F
$60.9B
$177K 0.01%
14,797
+3,981
+37% +$44.9K
TCRT icon
364
Alaunos Therapeutics
TCRT
$4.64M
$167K 0.01%
181
XOP icon
365
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.54B
$167K 0.01%
1,221
VATE icon
366
INNOVATE Corp
VATE
$106M
$161K 0.01%
3,058
VGT icon
367
Vanguard Information Technology ETF
VGT
$133B
$155K 0.01%
8,136
XLY icon
368
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
$149K 0.01%
3,318
EFG icon
369
iShares MSCI EAFE Growth ETF
EFG
$16.2B
$145K 0.01%
1,879
CNH
370
CNH Industrial
CNH
$13.3B
$145K 0.01%
13,867
+409
+3% +$4.12K
ACN icon
371
CALL
Accenture
ACN
$106B
$135K 0.01%
+1,000
New +$130K
VCIT icon
372
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$131K 0.01%
1,483
+726
+96% +$63.9K
XBI icon
373
State Street SPDR S&P Biotech ETF
XBI
$10B
$130K 0.01%
1,496
XLV icon
374
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
$129K 0.01%
1,576
HZNP
375
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$128K 0.01%
10,057
-200
-2% -$2.54K

Similar funds

Ballentine Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Ballentine Partners held 481 positions worth $1.81B, up 32% from $1.37B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Ballentine Partners deployed $410M of net new capital in Q3 2017, opening 48 new positions and adding to 103 existing holdings. Its largest new stake was Vanguard Total Stock Market ETF: 3,314,888 shares worth $429M.

By sector, the portfolio is most concentrated in Industrials at 3% of assets, down from 3.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $7.74M trimmed.

  • Ballentine Partners's largest Q3 2017 buy was Vanguard Total Stock Market ETF: 3,314,888 shares worth $429M.
  • Ballentine Partners added most to Forrester Research in Q3 2017, an estimated $10.1M increase.
  • Ballentine Partners's biggest Q3 2017 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $7.74M.
  • Ballentine Partners fully exited Zoe's Kitchen, Inc. in Q3 2017, selling an estimated $7.73M.
  • Ballentine Partners's ten largest holdings make up 61% of its $1.81B portfolio in Q3 2017.
  • Ballentine Partners opened 48 new positions and closed 49 in Q3 2017.
  • Ballentine Partners's portfolio value rose 32% quarter-over-quarter to $1.81B.

Based on Ballentine Partners's 13F filing for Q3 2017, filed 6 Nov 2017.